These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 3056649

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Decreased bioavailability of digoxin due to antacids and kaolin-pectin.
    Brown DD, Juhl RP.
    N Engl J Med; 1976 Nov 04; 295(19):1034-7. PubMed ID: 972657
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations.
    Bauer LA, Horn JR, Pettit H.
    Ther Drug Monit; 1996 Feb 04; 18(1):46-52. PubMed ID: 8848820
    [Abstract] [Full Text] [Related]

  • 5. Current status of cardiac glycoside drug interactions.
    Hooymans PM, Merkus FW.
    Clin Pharm; 1985 Feb 04; 4(4):404-13. PubMed ID: 2412751
    [Abstract] [Full Text] [Related]

  • 6. Understanding digoxin use in the elderly patient.
    Tsang P, Gerson B.
    Clin Lab Med; 1990 Sep 04; 10(3):479-92. PubMed ID: 2253445
    [Abstract] [Full Text] [Related]

  • 7. Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytes.
    Hedman A, Meijer DK.
    J Pharm Sci; 1998 Apr 04; 87(4):457-61. PubMed ID: 9548899
    [Abstract] [Full Text] [Related]

  • 8. Digoxin-quinidine and digoxin-amiodarone interactions: frequency of occurrence and monitoring in Australian repatriation hospitals.
    Freitag D, Bebee R, Sunderland B.
    J Clin Pharm Ther; 1995 Jun 04; 20(3):179-83. PubMed ID: 7593381
    [Abstract] [Full Text] [Related]

  • 9. Interaction of digoxin with activated dimethicone and other antacid constituents.
    McElnay JC, Harron DW, D'Arcy PF, Eagle MR.
    Experientia; 1979 Jan 15; 35(1):94. PubMed ID: 421811
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of kaolin--pectin suspension on digoxin bioavailability.
    Albert KS, Ayres JW, DiSanto AR, Weidler DJ, Sakmar E, Hallmark MR, Stoll RG, DeSante KA, Wagner JG.
    J Pharm Sci; 1978 Nov 15; 67(11):1582-6. PubMed ID: 712596
    [Abstract] [Full Text] [Related]

  • 14. [Interactions of digoxin with nifedipine and diltiazem].
    Halawa B, Mazurek W.
    Pol Tyg Lek; 1978 Nov 15; 45(23-24):467-9. PubMed ID: 2277790
    [Abstract] [Full Text] [Related]

  • 15. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
    Suematsu F, Yukawa E, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y.
    Biopharm Drug Dispos; 2002 Jul 15; 23(5):173-81. PubMed ID: 12116048
    [Abstract] [Full Text] [Related]

  • 16. Clinical digoxin toxicity in the aged in association with co-administered verapamil. A report of two cases and review of the literature.
    Gordon M, Goldenberg LM.
    J Am Geriatr Soc; 1986 Sep 15; 34(9):659-62. PubMed ID: 3734315
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
    Echizen H, Eichelbaum M.
    Clin Pharmacokinet; 1986 Sep 15; 11(6):425-49. PubMed ID: 3542336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.